CIS & Central Asian Pharmaceutical Markets Landscape 2019

CIS & Central Asian Pharmaceutical Markets Landscape 2019

Brief Summary

The collapse of the Soviet Union in 1991 led to the formation of independent republics, each of which sets its own unique path for further development. In this regard, each pharmaceutical market of the post-Soviet countries also has its own features. For many international companies, these markets still remain to be uncharted territory.

Nevertheless, the markets of the CIS countries are promising and have a great potential for growth. According to IQVIA experts, the pharmaceutical markets of the CIS countries in the coming years will grow by an average of 7.6%, which is about 1.5 times faster than the pharmaceutical markets of the developed countries.

We selected 7 ex-Soviet countries in order to give a general view of them, by comparing the main indicators and describing the main pharmaceutical distributors. This publication will help you, having tested the main landscape, to get an idea of the surveyed markets, and maybe to determine a general plan for further access to them.

What information you will find:
Distributor Description of the largest pharmaceutical distributors in each market Pharmacy Number of pharmacies in each country
Pharma Pharma consumption per capita Ratio The ratio of market shares of local and foreign companies, as well as Rx/OTC sales ratio
hospital Number of hospitals in each country doctors Number of doctors in each country
Series: Pharmaceutical country report
List of countries reviewed:
  • Armenia
  • Azerbaijan
  • Belarus
  • Georgia
  • Kazakhstan
  • Ukraine
  • Uzbekistan
Number of pages: 12
Price: FREE
Format: .pdf
Get the report: Download

Check out our new reports

Let's stay in touch

"UPharma Consulting"
Holosiivskiy avenue, 30B
office 58
Kyiv, 03039

Telephone: + 380 (97) 953 68 14